e-learning
resources
Barcelona 2013
Monday, 09.09.2013
Biomarkers, diagnosis and outcome of respiratory infections
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Blood urea nitrogen/ albumin ratio: Is it a new predictor for prognosis of community-acquired pneumonia?
E. Akpinar, D. Hosgün, B. Doganay, M. Gulhan (Ankara, Turkey)
Source:
Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections
Session:
Biomarkers, diagnosis and outcome of respiratory infections
Session type:
Thematic Poster Session
Number:
2705
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
E. Akpinar, D. Hosgün, B. Doganay, M. Gulhan (Ankara, Turkey). Blood urea nitrogen/ albumin ratio: Is it a new predictor for prognosis of community-acquired pneumonia?. Eur Respir J 2013; 42: Suppl. 57, 2705
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Middle-long term pulmonary abnormalities after severe COVID-19 pneumonia which required invasive ventilation
Related content which might interest you:
Individual monitoring of procalcitonin and C-reactive protein levels as a criterion for cancel of antibiotic therapy in patients with severe community-acquired pneumonia
Source: Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections
Year: 2013
Role of procalcitonin in predicting severity and in-hospital mortality in patients with community-acquired pneumonia
Source: International Congress 2016 – Community-acquired pneumonia: risk classes and management issues
Year: 2016
ICU-acquired pneumonia and PaO2/FIO2 value accuracy: A new paradigm?
Source: International Congress 2015 – Acute critical care: news from the ICU
Year: 2015
The neutrophil/lymphocyte ratio in predicting outcome for hospitalized patients with community-acquired pneumonia
Source: International Congress 2014 – Cells, biofilms and biomarkers in respiratory infections
Year: 2014
Immunoglobulin levels and severity of community-acquired pneumonia (CAP)
Source: International Congress 2014 – Pathogenesis and mechanisms of respiratory infections
Year: 2014
Clinical and laboratory predictors of survival in patients with severe community-acquired pneumonia (CAP)
Source: International Congress 2014 – Healthcare, prevention and adjunctive treatments in respiratory infections
Year: 2014
Microbiological vs non-microbiological confirmed nnventilator ICU-acquired pneumonia
Source: International Congress 2016 – Severe respiratory infections in the intensive care unit and pleural and fungal infections
Year: 2016
Could the early administration of antibiotics before admission improve the prognosis of pneumonia?
Source: International Congress 2015 – Pneumonia: determinants of clinical outcomes and potential strategies to improve its management
Year: 2015
Prognostic power of biomarkers to predict in-hospital and postdischarge mortality in community acquired pneumonia
Source: Annual Congress 2013 –A modern approach to lung diseases: from bronchi to pleura
Year: 2013
Physiological score SIPF (shock index and hypoxemia) is an accurate predictor of ICU admission in community-acquired pneumonia
Source: International Congress 2014 – Respiratory infections: inflammation and treatment
Year: 2014
Efficacy of ceftobiprole in intensive care unit (ICU) patients with hospital-acquired pneumonia (HAP)
Source: International Congress 2014 – Respiratory infections: inflammation and treatment
Year: 2014
Usefulness of procalcitonin as a predictor for bacteremia and prognosis in severe sepsis
Source: International Congress 2016 – Infections, sepsis, and pulmonary embolism
Year: 2016
Contribution of C-reactive protein to the diagnosis and assessment of severity of community-acquired pneumonia
Source: Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections
Year: 2013
Severe community-acquired pneumonia in alcoholic patients hospitalized in intensive care unit
Source: International Congress 2016 – Community-acquired pneumonia: risk classes and management issues
Year: 2016
Sequential measurements of procalcitonin levels in diagnosing ventilator-associated pneumonia
Source: Eur Respir J 2008; 31: 356-362
Year: 2008
Implications of identifying the pathogen in ventilator-associated pneumonia (VAP)
Source: Annual Congress 2013 –Infection, sepsis and outcomes in ICU
Year: 2013
Nursing and healthcare-associated pneumonia requiring hospital admission: Microbiology and clinical outcomes
Source: International Congress 2014 – Epidemiology, scores and outcomes of respiratory infections
Year: 2014
YKL-40 and CCL18 predict mortality in patients hospitalised with community-acquired pneumonia; an observational analysis
Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment
Year: 2016
The prognostic value of consecutive C-reactive protein measurements in community acquired pneumonia
Source: International Congress 2015 – CAP: prognostic factors in frail patients
Year: 2015
The role of procalcitonin in predicting severity and clinical course of aspiration pneumonia
Source: International Congress 2015 – CAP: prognostic factors in frail patients
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept